A Letter from School of Medicine Dean David Kessler.

Marilyn Stebbins, clinical professor in the UCSF School of Pharmacy, and Tim Cutler, assistant clinical professor, answer this latest round of Medicare Part D questions.

The deaths of two women who had reportedly used mifepristone (originally known as RU-486) to terminate their pregnancies have renewed questions about the drug's safety.

Researchers at the San Francisco VA Medical Center report that they have found a potential molecular cause for the aggressive growth and spread of human head and neck squamous cell carcinoma, a highly malignant form of cancer with a very high death rate.

In the first survey of its kind, UCSF wants to know what people think about Campus Life Services available at the satellite locations.

Famed UCSF biochemist Elizabeth Blackburn and legendary occupational health expert Joe LaDou advised graduate students to be wary of conflicts of interest and political and industry influence as they charged ahead with their careers.

Nonhlanhla Sukati, a nurse educator and researcher at the University of Swaziland, can't forget the face of a now-dead student nurse. It was ravaged not just by a dramatic rash – a herpes zoster caused by HIV/AIDS.

UCSF is well represented in the first Global Life Science Innovation Competition open to the public on April 21.

Jeffrey M. Drazen, editor-in-chief of the New England Journal of Medicine (NEJM), discussed the rise and fall of Vioxx and similar painkilling drugs at UCSF's Cole Hall Wednesday.